NEWS
![Debate from Arendalsuka](https://oslocancercluster.no/wp-content/uploads/2019/08/debate_web_edit-260x185.jpg)
Together for precision medicine
During Arendalsuka 2019, we arranged a breakfast meeting on the development of cancer treatments of the future, together with LMI and Kreftforeningen.
![Sune Justesen and Stephan Thorgrimsen from Immunitrack](https://oslocancercluster.no/wp-content/uploads/2019/08/ss3_fix-260x185.jpg)
New tool to improve cancer vaccines receives funding
Immunitrack has been awarded a grant from Eurostars to develop their prediction tool for cancer vaccines.
![Dr. Richard Stratford and Dr. Trevor Clancy, founders of OncoImmunity](https://oslocancercluster.no/wp-content/uploads/2019/08/IMG_0241_fix_2-260x185.jpg)
Norwegian AI-based cancer research gets a boost
The Japanese tech giant NEC Corporation has acquired OncoImmunity AS.
![Two women working on two laptops and smiling.](https://oslocancercluster.no/wp-content/uploads/2019/07/emma-dau-n_4iTY1KmDE-unsplash_computers_women_crop_web-260x185.jpg)
Cross-border courses in the Nordics
Oslo Cancer Cluster Incubator collaborates with partners in Sweden, Norway and Finland to help life science professionals learn from their neighbours.
![](https://oslocancercluster.no/wp-content/uploads/2019/04/New_members_2-260x185.jpg)
Meet our new members
We proudly present the new members that have joined our organisation during the second quarter of 2019.
![Three new board members of Oslo Cancer Cluster: Per Morten Sandset, Gunhild M. Maelandsmo and Cathrine Lofthus](https://oslocancercluster.no/wp-content/uploads/2019/07/three_new_board_members-260x185.jpg)
New board members
We are happy to welcome three new members to the board of Oslo Cancer Cluster. Find out what they had to say about entering their new positions.
![The Cell Lab at SINTEF. Photo: Thor Nielsen / SINTEF](https://oslocancercluster.no/wp-content/uploads/2019/06/immuno1_front-260x185.jpg)
SINTEF to develop methods in immuno-oncology
SINTEF is looking for new partners to develop methodology for cancer immunotherapy.
![Tor takes a mouthswab before in order to profile his DNA.](https://oslocancercluster.no/wp-content/uploads/2019/06/Tor_munnprøve_fix_16-9-260x185.jpg)
DNA profiling on the syllabus
Students got to try DNA profiling at a work placement at Thermo Fisher Scientific, arranged by Oslo Cancer Cluster and Ullern Upper Secondary School.
![Dr James Allison, Dr Padmanee Sharma](https://oslocancercluster.no/wp-content/uploads/2019/06/shutterstock_1285643596_web-260x185.jpg)
Nobel Prize winner joins Lytix Biopharma
The Nobel Laureate Dr James Allison and oncologist Dr Padmanee Sharma will become strategic advisors for our member Lytix BioPharma.